HIV antiretroviral therapy reduces circulating surfactant protein-D levels

HIV Med. 2011 Oct;12(9):580-1. doi: 10.1111/j.1468-1293.2011.00920.x.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • CD4-CD8 Ratio*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • Humans
  • Male
  • Pulmonary Surfactant-Associated Protein D / blood
  • Pulmonary Surfactant-Associated Protein D / drug effects*
  • Pulmonary Surfactant-Associated Protein D / immunology
  • Virus Replication / drug effects*
  • Virus Replication / immunology

Substances

  • Anti-HIV Agents
  • Pulmonary Surfactant-Associated Protein D

Associated data

  • ClinicalTrials.gov/NCT00783614
  • ClinicalTrials.gov/NCT00867048